U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07079306) titled 'ChatGPT-Supported Text Messaging Program for Smoking Cessation' on July 14.
Brief Summary: The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Study Start Date: July 21
Study Type: INTERVENTIONAL
Condition:
Smoking Cessation
Intervention:
BEHAVIORAL: BeFree+Bot
Text messaging program called BeFree and access to BBot, ChatGPT chatbot
BEHAVIORAL: BeFree
Text messaging program...